Literature DB >> 23224214

Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations.

Cathryn Poulton1, Renske Oegema, Daphne Heijsman, Jeannette Hoogeboom, Rachel Schot, Hans Stroink, Michèl A Willemsen, Frans W Verheijen, Peter van de Spek, Andreas Kremer, Grazia M S Mancini.   

Abstract

We present a neurodegenerative disorder starting in early childhood of two brothers consisting of severe progressive polyneuropathy, severe progressive cerebellar atrophy, microcephaly, mild epilepsy, and intellectual disability. The cause of this rare syndrome was found to be a homozygous mutation (c.1250_1266dup, resulting in a frameshift p.Thr424GlyfsX48) in PNKP, identified by applying homozygosity mapping and whole-genome sequencing. Mutations in PNKP have previously been associated with a syndrome of microcephaly, seizures and developmental delay (MIM 613402), but not with a neurodegenerative disorder. PNKP is a dual-function enzyme with a key role in different pathways of DNA damage repair. DNA repair disorders can result in accelerated cell death, leading to underdevelopment and neurodegeneration. In skin fibroblasts from both affected individuals, we show increased susceptibility to apoptosis under stress conditions and reduced PNKP expression. PNKP is known to interact with DNA repair proteins involved in the onset of polyneuropathy and cerebellar degeneration; therefore, our findings explain this novel phenotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224214     DOI: 10.1007/s10048-012-0351-8

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  23 in total

1.  Microcephaly with simplified gyration, epilepsy, and infantile diabetes linked to inappropriate apoptosis of neural progenitors.

Authors:  Cathryn J Poulton; Rachel Schot; Sima Kheradmand Kia; Marta Jones; Frans W Verheijen; Hanka Venselaar; Marie-Claire Y de Wit; Esther de Graaff; Aida M Bertoli-Avella; Grazia M S Mancini
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

2.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

3.  Xeroderma pigmentosum group G with severe neurological involvement and features of Cockayne syndrome in infancy.

Authors:  D I Zafeiriou; F Thorel; A Andreou; W J Kleijer; A Raams; V H Garritsen; N Gombakis; N G Jaspers; S G Clarkson
Journal:  Pediatr Res       Date:  2001-03       Impact factor: 3.756

4.  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy.

Authors:  James R Lupski; Jeffrey G Reid; Claudia Gonzaga-Jauregui; David Rio Deiros; David C Y Chen; Lynne Nazareth; Matthew Bainbridge; Huyen Dinh; Chyn Jing; David A Wheeler; Amy L McGuire; Feng Zhang; Pawel Stankiewicz; John J Halperin; Chengyong Yang; Curtis Gehman; Danwei Guo; Rola K Irikat; Warren Tom; Nick J Fantin; Donna M Muzny; Richard A Gibbs
Journal:  N Engl J Med       Date:  2010-03-10       Impact factor: 91.245

5.  Dual modes of interaction between XRCC4 and polynucleotide kinase/phosphatase: implications for nonhomologous end joining.

Authors:  Rajam S Mani; Yaping Yu; Shujuan Fang; Meiling Lu; Mesfin Fanta; Angela E Zolner; Nasser Tahbaz; Dale A Ramsden; David W Litchfield; Susan P Lees-Miller; Michael Weinfeld
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

6.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays.

Authors:  Yasuhito Nannya; Masashi Sanada; Kumi Nakazaki; Noriko Hosoya; Lili Wang; Akira Hangaishi; Mineo Kurokawa; Shigeru Chiba; Dione K Bailey; Giulia C Kennedy; Seishi Ogawa
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

7.  Mutations in PNKP cause microcephaly, seizures and defects in DNA repair.

Authors:  Jun Shen; Edward C Gilmore; Christine A Marshall; Mary Haddadin; John J Reynolds; Wafaa Eyaid; Adria Bodell; Brenda Barry; Danielle Gleason; Kathryn Allen; Vijay S Ganesh; Bernard S Chang; Arthur Grix; R Sean Hill; Meral Topcu; Keith W Caldecott; A James Barkovich; Christopher A Walsh
Journal:  Nat Genet       Date:  2010-01-31       Impact factor: 38.330

Review 8.  Single-strand break repair and genetic disease.

Authors:  Keith W Caldecott
Journal:  Nat Rev Genet       Date:  2008-08       Impact factor: 53.242

9.  Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA strand break repair.

Authors:  John J Reynolds; Alexandra K Walker; Edward C Gilmore; Christopher A Walsh; Keith W Caldecott
Journal:  Nucleic Acids Res       Date:  2012-04-15       Impact factor: 16.971

10.  Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome.

Authors:  D L Mallery; B Tanganelli; S Colella; H Steingrimsdottir; A J van Gool; C Troelstra; M Stefanini; A R Lehmann
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

View more
  30 in total

1.  Ataxia with Oculomotor Apraxia Type 4 with PNKP Common "Portuguese" and Novel Mutations in Two Belarusian Families.

Authors:  Galina E Rudenskaya; Andrey V Marakhonov; Olga A Shchagina; Ekaterina R Lozier; Elena L Dadali; Irina A Akimova; Nika V Petrova; Fedor A Konovalov
Journal:  J Pediatr Genet       Date:  2019-03-27

2.  Polynucleotide kinase-phosphatase enables neurogenesis via multiple DNA repair pathways to maintain genome stability.

Authors:  Mikio Shimada; Lavinia C Dumitrache; Helen R Russell; Peter J McKinnon
Journal:  EMBO J       Date:  2015-08-19       Impact factor: 11.598

Review 3.  Coordination of DNA single strand break repair.

Authors:  Rachel Abbotts; David M Wilson
Journal:  Free Radic Biol Med       Date:  2016-11-24       Impact factor: 7.376

Review 4.  Neurological disorders associated with DNA strand-break processing enzymes.

Authors:  Bingcheng Jiang; J N Mark Glover; Michael Weinfeld
Journal:  Mech Ageing Dev       Date:  2016-07-25       Impact factor: 5.432

Review 5.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

6.  Causative novel PNKP mutations and concomitant PCDH15 mutations in a patient with microcephaly with early-onset seizures and developmental delay syndrome and hearing loss.

Authors:  Mitsuko Nakashima; Kyoko Takano; Hitoshi Osaka; Noriko Aida; Yoshinori Tsurusaki; Noriko Miyake; Hirotomo Saitsu; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2014-06-26       Impact factor: 3.172

Review 7.  Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease.

Authors:  Lavinia C Dumitrache; Peter J McKinnon
Journal:  Mech Ageing Dev       Date:  2016-04-26       Impact factor: 5.432

Review 8.  DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors.

Authors:  Edward C Gilmore
Journal:  Neurogenetics       Date:  2014-07-20       Impact factor: 2.660

9.  The ATM signaling network in development and disease.

Authors:  Travis H Stracker; Ignasi Roig; Philip A Knobel; Marko Marjanović
Journal:  Front Genet       Date:  2013-03-25       Impact factor: 4.599

10.  A Novel c.968C > T homozygous Mutation in the Polynucleotide Kinase 3' - Phosphatase Gene Related to the Syndrome of Microcephaly, Seizures, and Developmental Delay.

Authors:  Carlos Marcilla Vázquez; María Del Carmen Carrascosa Romero; Andrés Martínez Gutiérrez; María Baquero Cano; Blanca Alfaro Ponce; María Jesús Dabad Moreno
Journal:  J Pediatr Genet       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.